Sumitomo Mitsui Trust Holdings, Inc. Adaptive Biotechnologies Corp Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$142 Billion
Q3 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 7,733,884 shares of ADPT stock, worth $49.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,733,884

Previous 6,899,631 12.09%

Holding current value

$49.4 Million

Previous $25 Million 58.54%

% of portfolio

0.03%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$3.37 - $5.12 $2.81 Million - $4.27 Million	834,253 Added 12.09%	7,733,884 $39.6 Million
Q2 2024 Jul 19, 2024	BUY	$2.34 - $3.96 $1.69 Million - $2.86 Million	722,924 Added 11.7%	6,899,631 $25 Million
Q1 2024 Apr 19, 2024	SELL	$2.88 - $4.8 $964,661 - $1.61 Million	-334,952 Reduced 5.14%	6,176,707 $19.8 Million
Q4 2023 Jan 30, 2024	SELL	$3.46 - $5.33 $205,108 - $315,962	-59,280 Reduced 0.9%	6,511,659 $31.9 Million
Q3 2023 Oct 30, 2023	BUY	$5.07 - $8.44 $947,542 - $1.58 Million	186,892 Added 2.93%	6,570,939 $35.8 Million
Q2 2023 Jul 31, 2023	BUY	$6.19 - $8.78 $6.57 Million - $9.32 Million	1,061,511 Added 19.94%	6,384,047 $42.8 Million
Q1 2023 Apr 27, 2023	SELL	$7.8 - $10.11 $232,276 - $301,065	-29,779 Reduced 0.56%	5,322,536 $47 Million
Q4 2022 Jan 30, 2023	BUY	$6.26 - $9.34 $3.22 Million - $4.8 Million	514,124 Added 10.63%	5,352,315 $40.9 Million
Q3 2022 Oct 21, 2022	BUY	$6.5 - $12.67 $1.43 Million - $2.78 Million	219,792 Added 4.76%	4,838,191 $34.4 Million
Q2 2022 Jul 26, 2022	BUY	$6.4 - $14.73 $3.11 Million - $7.16 Million	486,339 Added 11.77%	4,618,399 $37.4 Million
Q1 2022 Apr 27, 2022	BUY	$10.12 - $28.9 $9.48 Million - $27.1 Million	936,614 Added 29.31%	4,132,060 $57.4 Million
Q4 2021 Feb 02, 2022	BUY	$25.17 - $36.85 $28.5 Million - $41.8 Million	1,133,445 Added 54.97%	3,195,446 $89.7 Million
Q3 2021 Oct 25, 2021	BUY	$30.02 - $39.87 $7.15 Million - $9.49 Million	238,060 Added 13.05%	2,062,001 $70.1 Million
Q2 2021 Aug 02, 2021	BUY	$32.22 - $44.59 $44.9 Million - $62.2 Million	1,394,838 Added 325.06%	1,823,941 $74.5 Million
Q1 2021 Apr 30, 2021	BUY	$37.26 - $67.74 $7 Million - $12.7 Million	187,956 Added 77.94%	429,103 $17.3 Million
Q4 2020 Feb 05, 2021	BUY	$45.01 - $65.47 $1.31 Million - $1.9 Million	29,084 Added 13.71%	241,147 $14.3 Million
Q3 2020 Oct 30, 2020	BUY	$35.79 - $48.81 $749,657 - $1.02 Million	20,946 Added 10.96%	212,063 $10.3 Million
Q2 2020 Jul 27, 2020	BUY	$24.95 - $48.38 $4.23 Million - $8.2 Million	169,517 Added 784.8%	191,117 $9.25 Million
Q1 2020 Apr 27, 2020	BUY	$16.96 - $34.16 $366,336 - $737,855	21,600 New	21,600 $600,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Adaptive Biotechnologies Corp Transaction History